Emerging Trends: Decentralised to Home-based Clinical Trials
The landscape of cancer care is evolving, with startups changing the field by bringing care to patients' homes.
Exploring Gen AI in the Pharmaceutical Industry
Gen AI in pharma is an emerging field that leverages AI to enhance various aspects of the pharmaceutical industry.
Unlocking AI's Potential in Medical Affairs
AI has significant potential to unlock new opportunities in medical affairs within the pharma industry.
Managing Risks and Maximising ROI Strategies
Managing risks and maximising ROI is the new mantra of digital health investors.
Where is Gen AI generating ROI?
Patient & Site Engagement: How Can Technology Improve Trial Experiences
In the dynamic landscape of clinical trials, technology stands as a transformative force, reshaping patient and site engagement for the better.
How Digital Diagnostics Enable Precision Medicine
The acceleration of advanced analytics, propelled by artificial intelligence and Big Data, is expanding possibilities to unlock the power of collected data.
PDT 2.0: The Future of Prescription Digital Therapeutics
Big Tech and Pharma: Will they, won't they?
As Big Tech seeks to expand their footprint in the health industry, the dynamics of their relationship with Pharma are under scrutiny.
BYOD: What's your Wearable of Choice?
Wearables, like smartwatches and fitness trackers, have transformed patient health monitoring, providing real-time data for personalised care.
Tech-Enabled Health in Cardiovascular Disease
The integration of technology in cardiovascular disease (CVD) management holds significant potential for pharma and healthcare alike.
Redesigning Patient Experiences: Infusion Therapies
Game Changer? DTx on Drug Labels
Digital Pain Management: Does it Work?
Lessons in Therapy: What Diabetes Can Teach Other Chronic Diseases
Multi-Condition SaMD: Regulatory Requirements and Future Implications
Designing Personalised Patient Experience for Pharma Brands
In the current landscape, designing personalised patient experiences for pharma brands is both a challenge and an opportunity.
Health is Wealth in Hindsight: Leveraging Digital Health for Prevention
Digital health is emerging as a powerful ally in the realm of preventive healthcare, reshaping the landscape by offering innovative solutions and transformative strategies.
What Does Innovation Look Like in Neurodegenerative Diseases?
Digital health technologies hold potential to revolutionise the patient journey in neurodegenerative disease, from early detection to ongoing management and support.
Quantifying the Benefits of Digital Biomarkers in Pharma
The pharmaceutical industry faces a constant challenge: demonstrating the true value of innovative solutions.
It's Getting Hot in Here! Innovation for Menopause
Innovation in menopause, coupled with advancements in digital health, is revolutionising the landscape of women's health and wellness during this life stage.
Innovation in Senior Care
From advanced healthcare technologies to novel care delivery models, the landscape of senior care is evolving to meet the diverse and evolving needs of ageing individuals.
DTx: A Comeback?
Inflammatory Conditions: Trigger 360 Degree Care
Inflammatory conditions, encompassing a myriad of diseases from arthritis to inflammatory bowel diseases, pose significant challenges to both patients and healthcare providers worldwide. T
GenAI Doctors: Can they be Trusted?
The algorithms powering GenAI Doctors are only as reliable as the data they are trained on, and biases within that data may inadvertently impact their recommendations.
Do Accelerators Work to Nurture Innovation?
How to Scale Partnerships Between Lifesciences and Digital Health Companies?
The Evolving Landscape of Digital Measures in Pharma
Customer Experience is a New Role in Pharma - What Does it Really Mean?
Commercialisation Models for PDT's
Commercialisation models for PDTs are still evolving. It’s not always a straightforward process of checking a box for approval or determining whether a PDT should be over-the-counter or prescription-based.
Repositioning the Role of DTx in the Industry
Repositioning the role of DTx is a complex and multifaceted task that requires addressing challenges related to reimbursement, alignment with public health priorities, clarity on pathways to market, and provider engagement.
Tech Enabled Change in Oncology Workflows
The demand for oncology services is increasing, while the supply for oncologists is decreasing. This creates immense pressure to meet the growing demand for cancer care.
Navigating Diverse Markets for Digital Health Success
Success in diverse digital health markets requires more than just understanding the unique challenges and opportunities they present.
The Future of Companion Diagnostics - Digital Biomarkers
The integration of digital technologies into healthcare has opened up new avenues for personalised medicine and patient-centred care.
Real World Data in Clinical Trials: Benefits and Best Practices
The utilisation of RWD provides numerous benefits, including improved external validity, broader patient representation, longitudinal data analysis, and improved post-market surveillance.
Customer Experience is a New Role in Pharma - What Does it Really Mean?
The pharma industry is increasingly shifting towards prioritising the needs and satisfaction of patients and healthcare providers, oftentimes through technology.
Obesity Management: Convergence Of Market Shaping Drugs And Virtual Care
The combination of market-shaping drugs and virtual care offers a promising solution to the complex and widespread problem of obesity.
Pharmacy as a Catalyst to Scale Digital Health
As digital health continues to revolutionise the healthcare industry, pharmacies are poised to play a crucial role in scaling these innovative technologies.
The Microbiome: The Gut-Mental-Digital Connection
The fascinating area of research surrounding the human microbiome includes exploring the intriguing connection between the gut microbiome and mental health.
Scientific Exchange
From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices
Collection of data in the real world is ubiquitous. Some of the medical device vendors fully utilize this trend while others are in the early stages of exploring how different data sources can support different use cases throughout the medical devices lifecycle.
Do Accelerators Work to Nurture Innovation?
Accelerators play a crucial role in nurturing innovation in pharma by bringing together diverse and innovative stakeholders to create a collaborative ecosystem that fosters the exchange of ideas, expertise, and best practices most conducive to breakthrough discoveries and advancements.
The Complete Story: Using RWE to Better Understand the Patient Experience
The Role of AI Across the Clinical Trial Landscape
Clinical trials face hurdles in patient selection, recruitment, and retention, causing delays and insufficient participation.
How to Scale Partnerships Between Lifesciences and Digital Health Companies?
Pharma companies have identified technology as an opportunity to deliver more value to their patients and clinicians and differentiate from other competitors.
Revolutionising Pharma: AI's Impact on the Value Chain
The pharma sector is harnessing the power of AI across various key areas.
Should AI Have a Role in Mental Health Therapy?
Exploring the role of AI in mental health therapy can revolutionise access, affordability, and effectiveness of treatment for countless individuals.
Scaling Success & Profitability in Digital Health
Scaling up a digital health business requires careful planning and execution.
DTx: A Comeback?
Digital therapeutics (DTx) has been a rapidly growing sector in healthcare, attracting significant investment. However, recent challenges, including market conditions and financing difficulties, have cast a shadow over the industry.
Navigating AI Regulation in Healthcare
The regulatory landscape for AI in healthcare can be quite unclear and challenging to navigate for manufacturers and developers.
PDT 2.0: The Future of Prescription Digital Therapeutics
Prescription digital therapeutics were the centre of all attention in the past years with millions of funding dollars flowing in with the promise of a bright future.
Advancing Digital Oncology: the Provider Perspective
For providers, it is crucial to prioritise opportunities for innovation in oncology and consider equity and inclusion when developing digital solutions. While digital innovation is not a cure-all for cancer, it can greatly impact patient care if we embrace solutions that have been designed for the complexities of the disease.
The Science of Digital Patient Engagement
Digital patient engagement is a multidisciplinary field that combines various fields and research. It encompasses neurological requirements for behavioural change, guiding principles for sustained engagement, mechanisms for behavioural economic activation, principles of digital game design, and stages of behaviour change.
Pharma and Telehealth: Evolving Parameters of Engagement
Pharma and telehealth hold the key to a future where healthcare is accessible, efficient, and patient-centred.
Does AI Guarantee ROI?
The buzz surrounding AI's role in healthcare is undeniable. Yet, amidst these discussions, a key question remains: Where should AI be harnessed to truly optimize return-on-investment (ROI)?
Designing Personalised Patient Experience for Pharma Brands
In the current landscape, designing personalised patient experiences for pharma brands is both a challenge and an opportunity.
PDT 2.0: The Future of Prescription Digital Therapeutics
The future of prescription digital therapeutics holds immense potential in revolutionising healthcare delivery and improving health outcomes.
Evaluating Health Economic Outcomes of DTx
2023 has been a challenging year for DTx, and now, more than ever, it has become increasingly important for DTx solutions to showcase robust health economics to secure stakeholder buy-in.
Enhancing Patient Experiences with Data-Driven Insights
In the modern healthcare landscape, the importance of leveraging data-driven insights to enhance patient experiences cannot be overstated. Pharmaceutical companies need to connect with patients because it can bring about big changes in how healthcare is provided
Pharma's Role in Remote Patient Monitoring in Oncology
Remote patient monitoring (RPM) is a key component of digital health, especially in the field of oncology.
MedTech: New Revenue Opportunities with Digital, Data and Connectivity
Are you struggling to establish digital as a cornerstone of your revenue generation strategy? Then this session is for you!
Business Models for Virtual Care Delivery
In a market progressively gravitating toward decentralised, consumer-centric healthcare delivery, the business models we use for virtual care must adapt and grow too. Different approaches are constantly emerging, and there’s no one-size-fits-all solution.
Digital Biomarkers in Neurology: Early Diagnosis & Disease Management
Neurological disorders, given their intricate nature and often elusive markers, pose a significant challenge to neurologists striving for early diagnosis and effective treatment.
Sustainable Business Models for Remote Patient Monitoring Solutions
Pharma 3.0: A framework for doing digital health better
Digital health’s interaction with pharma is evolving; it has to evolve. Join this expert led discussion where we will deep dive into the future of Pharma. Seats are limited so apply now to secure your place.
Upskilling Medical Affairs for Digital Health
In an era of digital transformation, the way in which we care and treat patients is fundamentally being altered.
Evidence Generation: What payers are looking for
Establishing the effectiveness of your solutions and securing reimbursement can be a daunting task. In the evolving reimbursement landscape, presenting a compelling value proposition and robust evidence base becomes crucial.
Designing Agile and Responsive Pharma Patient Experience to Improve Drug Adherence
As the landscape of pharmaceuticals evolves, understanding and adapting to emerging, tech-enabled patient journeys is critical. Improving these journeys is central to enriching patient experiences and, by extension, improving treatment adherence.
Balancing AI and Human Involvement in Digital Health
As artificial intelligence gains traction in healthcare, the industry finds itself at a crossroads, torn between the anticipation of AI's vast potential and the concerns surrounding ethical and patient safety issues. Join HealthXL as we deep dive into this session, register now to secure your place.
Quantifying the Benefits of Digital Biomarkers in Pharma
This session is an invite-only meeting. To find out more please contact us.
With the rise of connected sensor technologies, and wearable devices that can offer objective, continuous patient measurements, healthcare stakeholders are presented with a wealth of opportunities to innovate how we measure health.
Mental Health: Getting your D2C Solution to be the Consumer's Top Pick
Compared to other therapeutic areas, mental health presents itself as an area ripe for sustainable direct-to-consumer (D2C) business models. Join us as we delve into these trends within the digital mental health landscape, and explore effective strategies when going down the D2C route.
Are open source DTx solutions the path to scalability?
Since the inception of medicine, practitioners have been sharing observations and best practices.
How Can Pharma Companies Get the Most Out of a Platform Approach?
With new platform technologies emerging, there is an opportunity to elevate pharma’s digital initiatives to a more flexible and globally compliant framework that can scale across multiple markets and therapy areas. Join your peers in this interactive discussion. Seats are limited so apply now to secure your place.
From Algorithms to Assets: Monetising Real-World Patient Data with AI
Artificial Intelligence (AI) is disrupting traditional business models by extracting deeper insights from diverse data sets. Join HealthXL in this meeting to deep dive into this topic with your peers working in this space. Seats are limited so apply now to secure your place.
Adherence in the U.S: Are We Making the Right Assessments and How Can Improvements Be Made?
The patient experience is becoming increasingly recognised as a major component of chronic condition treatment delivery. Join us in this roundtable discussion led by Health Beacon where we will deep dive into this topic. Spaces are limited so apply now to secure your seat.
Adoption Of Digital Mental Health Solutions: How Cultural Differences Affect Uptake
Cultural context significantly influences perceptions and approaches to mental health conditions.
Advancing Digital Oncology Through Public-Private Partnerships
We have made remarkable progress in oncology treatments, yet, many patients are still grappling with basic, and often preventable, barriers to care.
Partnership Roadmap with Life Sciences Companies for Digital Health in Cardiometabolic Diseases
Life sciences companies and digital health startups are teaming up to improve outcomes and reduce the burden of cardiometabolic diseases. Join HealthXL in this session to deep dive into this topic. Apply now to secure your place.
Patients as Consumers: Why Pharma Must Deliver a Convenient, Connected Patient Experience
The consumerisation of healthcare has given rise to a new generation of patient with heightened expectations for seamless and personalised experiences.
The New Role of Medical Affairs: Enabling Digital HCP Engagement and Scientific Communication
Digital health is changing the Medical Affairs (MA) function; the introduction of connected technology alongside drugs provides MA with new methods of reaching patients and their physicians.
Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this exclusive roundtable where we will discuss the highlights from our recent HealthXL Pharma 3.0 report and how pharma can do digital health better in the next few years.
Adherence in the U.S: Are We Making the Right Assessments and How Can Improvements Be Made?
The patient experience is becoming increasingly recognised as a major component of chronic condition treatment delivery. Join us in this roundtable discussion led by Health Beacon where we will deep dive into this topic. Spaces are limited so apply now to secure your seat.
Digital Assessments in Remote Trials: Exploring Pharma's Implementation Strategies
The integration of digital assessments, digital-enabled measures as well as novel digital biomarkers, into clinical trials has created a new era of patient-centric and decentralised trials. Apply now to join your peers in this discussion. Seats are limited so apply now to secure your place.
Beyond Point Solutions: Will an Ecosystem Approach Unlock Digital Health’s Full Potential for Pharma?
Point solutions have been the norm for pharma to date. Brands create an app in isolation, often duplicating underlying infrastructure already created for other siloed products elsewhere in the company. Join your peers in this discussion led by Appnovation. Spaces are limited so apply now to secure your place.
AI-driven Innovations for Clinical Decision Making
Artificial intelligence (AI) is beginning to seep into all aspects of healthcare - but its role as a tool for clinical decision making is still under scrutiny. Apply now to join your peers in this discussion. Spaces are limited so register now to secure your place.
Preparing Investment Rounds: Best Practices for DTx Startups
In the face of macroeconomic challenges and a tightening financial landscape, DTx startups are experiencing an intensified competition for investment. Join HealthXl in this peer led discussion to deep dive into this topic. Seats are limited so apply now to secure your place.
Innovation showcase: Remote Patient Monitoring (RPM) for Cardiovascular Diseases
In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Seats are limited to 3 Pharma/Medtech/VC and 3 digital health companies so we can pair you 1-2-1. Apply now to book your place!
Existing and New Distribution Channels for DTx
Digital therapeutics (DTx) are yet to show success at scale with traditional salesforce distribution channels. Apply now to discuss this further with your peers working in this space.
Remote Patient Monitoring to Improve Surgical Workflows
Remote patient monitoring (RPM) technologies can benefit the entire surgical workflow, by allowing preoperative and postoperative monitoring that improves patient experience and reduces the overall cost of care. Apply now to secure your place as we deep dive into this topic.
Digital Health to Overcome the Siloed Care Pathways in Immunology
Digital health care pathways in immunology can become siloed due to the fragmentation of healthcare services and the lack of interoperability among healthcare systems and providers. Apply now to join this session and deep dive into this topic with your peers working in this space.
Integrating Oncology Digital Health into Clinical Practices
The benefits of digital technologies in oncology are undeniable; however, effectively demonstrating their value to end users is pivotal for the success of these products. Apply now to join your peers in this interactive discussion. Spaces are limited so apply now to secure your seat.
Empowering Primary Care with Digital Health for Equitable Mental Wellbeing
The primary care model has become a key focus in mental health in the US due to a shortage of therapists and specialists. Join HealthXL in this meeting as we deep dive into this topic. Seats are limited so apply now to secure your place.
GPT for Life Sciences - What Does The Future Hold?
What does ‘a good DTx’ look like?
When it comes to digital therapeutics (DTx), there are many permutations, and what distinguishes a ‘good DTx’ can be difficult to define in a space that is constantly evolving. Apply now to join HealthXL in this session where we will deep dive into this topic. Apply now to secure your space, seats are limited.
Role Of Digital Health Across Brand Life Cycle In Pharma
Throughout each phase of a drug's life cycle, it is crucial to optimise both clinical and product value: from pre-launch and launch, to growth, maturity, and eventual decline. Apply now to join your peers to discuss this topic further.
The Power of Mental Health Improvement Tools: Showing Pharma Their Potential Across All Therapeutic Areas
While pharma is beginning to recognise the power of digital mental health tools, it is still challenging to get the true value recognition for these solutions. Join your peers to deep dive into this topic. Seats are limited so apply now to secure your place.
How to Structure a Deal Between DTx and Pharma Companies?
Structuring a deal between pharmaceutical companies and digital therapeutics (DTx) companies can be complex, and the specifics will depend on various factors, including the therapeutic area to which the deal pertains, market size, and development stage of the DTx solution. Apply now to join your peers in this discussion.
Pharma Brand Strategies for Driving HCP Engagement and Adoption with Sponsored DTx Solutions
In the aftermath of COVID-19, the patient journey has undergone considerable changes as digital tools and technologies have become increasingly integrated into the journey. Seats are limited. Apply now to join your peers in this discussion.
The Role of Medical Affairs in Advancing Digital Health
Medical affairs (MA) teams play a critical role in communicating with the wider medical fraternity and commercially supporting pharmacologics. Join us in this session where we will deep dive into this topic. Seats are limited so apply now to secure your place.
Beyond the Provider: Alternative Paths to Adoption of Oncology Digital Health Solutions
Engaging healthcare providers is crucial to drive patient adoption of digital health solutions. Apply now to join HealthXL in this peer to peer discussion.
Hybrid Care: How Could the Players in the Ecosystem Work Together to Make It Impactful?
Whilst the Covid-19 outbreak created strong incentives to go digital, it also demonstrated the value of in-person interactions. Apply now to join this session and dive deeper into this topic with your peers working in this space.
Are Hospitals the Right Partner for Digital Health Companies in Oncology?
Digital health in oncology is still a very raw and undefined practice with companies still searching for a best approach to put these solutions into the patients' hands. Join this peer-to-peer conversation to deep dive into this discussion.
Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss the highlights from the report and how pharma can do digital health better in the next few years.
The Potential of OTC DTx Solutions
Curious about what is in store for the future of OTC DTx solutions? Join in the conversation with our expert panel to find out! Spaces are limited so apply now to secure your place.
Embracing Digital Health for Hospital at Home Solutions
By reducing hospital admissions, and in-person care services, digital hospital at home solutions are emerging as cost-effective services for health systems. Join HealthXL in this discussion. Apply now to secure your place.
Panel Discussion: Patient Engagement Through a Digital Health Front Door
The digital front door is a powerful approach to improve patient engagement and care delivery, but it requires a patient-centric and holistic approach to be successful. Apply now to join HealthXL in this panel discussion with leaders working in this space.
Data Monetisation for MedTech Companies
With the proliferation of digital health solutions developed and commercialised by MedTech firms, the volume of healthcare data they generate is expanding rapidly. Apply now to join your peers and discuss this topic further.
Pharmacies in the US as a Distribution Model for DTx
The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.
Innovation Showcase: Digital Biomarkers in CNS and Cognition Assessment
In this innovation showcase, 3 Digital Biomarkers companies working on CNS and cognition assessment will meet 121 with 3 Pharma/Medtech/Investors to discuss mutual challenges when building successful collaborations. Seats are limited to 3 Pharma/Medtech/Investors and 3 Digital Biomarkers companies so we can pair you 1-2-1. Apply now to book your place!
Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss how pharma can do digital health better in the next few years.
Scalable Market Access Strategies Targeting Payers in the US
Despite DTx gaining traction in terms of investment, adoption still remains a challenge, and DTx companies struggle to secure reimbursement. Apply now to join your peers as we deep dive into this topic.
Patient Engagement Metrics in Digital Health for Oncology
Measuring patient engagement with digital health solutions is crucial to ensure the digital intervention is impactful and helps improve patient outcomes. Join this discussion to dive deeper into this topic with your peers working in this space. Seats are limited to apply now to secure your place.
Extended-Reality (XR) Solutions in Mental Health and Substance Use Disorders
Extended Reality (XR) is a powerful technology that can be used anywhere, at any time. Join HealthXL in this meeting as we discuss this topic further. Seats are limited so apply now to secure your place.
Beyond Pharma: Finding the Best Commercial Partner for Digital Health in Oncology
Whilst digital health startups in oncology have tried to build prosperous partnerships with pharma, there are no outstanding results yet, and it has proven hard to make it work. Seats are limited for this event so apply now to deep dive into this topic with your peers.
Innovation Showcase: Digital Health Solutions in Oncology
In this innovation showcase, 3 Digital Health companies in Oncology will meet 121 with 3 Pharma/Medtech/Investors/Healthcare Providers, to discuss mutual challenges when building successful collaborations. Apply now to join this session as seats are limited.
Standards for Robust Evidence from Digital Health in Oncology
Due to the lack of industry-wide evidence frameworks for digital health solutions in oncology, regulators' and payers' requirements are usually the same as drugs. Join HealthXL in this meeting to deep dive into this topic.
Digital Biomarkers for Mental Health Evaluation and Management
Unlike other therapeutic areas, mental health evaluation and management can be a bit of an art, and at times relies on subjectivity in the outcomes analysis. Join this meeting to discuss this topic further with others working in this space. Places are limited so apply now to avoid disappointment.
The Role of the Consumer Experience in DTx
As technology advances in all sectors (e.g. fintech, entertainment, etc), consumer behaviour changes and the expectations on user experience are higher than before. Apply now to secure your place in this meeting where you will dive deeper into this topic with your peers.
Business Opportunities for Digital Health in Autoimmune Conditions: Upcoming Blockbuster Drugs
Millions of people worldwide suffer from autoimmune conditions such as rheumatoid arthritis (RA), psoriasis, lupus, Crohn's disease, multiple sclerosis, atopic dermatitis, to name a few. Join this meeting to deep dive into this topic in the Immunology Meeting Series. Seats are limited so apply now to secure your place.
Product Differentiation for Digital Health Solutions in the Cardiometabolic Disease Area
In the past few years, digital health solutions have proven to be helpful in preventing and managing cardiometabolic diseases remotely, leading to better health outcomes and less hospitalizations, emergency visits, and in-office visits.
Masterclass: How to Move from DTx Point Solutions to Platforms?
Why is now the right time to move from DTx point solutions to platforms? How to bring this to life? Join this meeting to discuss this topic further with your peers. Apply now to secure your seat.
Healthcare Provider Adoption of Digital Solutions in Mental Health
How can we help healthcare providers and health systems sift through the universe of digital solutions in mental health? How can digital health companies engage providers? Join this meeting to deep dive into this topic with your peers. Spaces are limited so apply now to secure your place.
Digital Health for Trigger Management in Autoimmune Conditions
It can be hard for HCPs to provide precise medical decisions in autoimmune conditions due to the patient variability and the trigger events not being fully understood. Join other senior leaders in this meeting to discuss this topic further.
Increase DTx Market Access and Adoption via Precision Patient Engagement
Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Apply now to deep dive into this topic with your peers working in this space.
How Can Virtual Care Solutions Help Health Systems Bounce Back After Covid?
Health systems have been shocked in a way that has never been seen before with the COVID-19 pandemic. Join HealthXL in this meeting to discuss this topic with your peers working in this space.
Revenue Generation in Pharma-DTx Partnerships
Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. Apply now to secure your place in this Digital Health meeting.
The Intersection between DTx and Human Coaching in Mental Health
The connection between DTx and human coaching in mental health can weave together a more precise, personalized, and connected care experience. Apply now to join this meeting to discuss this topic further with your peers.
Innovation Showcase: Remote Patient Monitoring Programs in Oncology
In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.
Innovative Distribution Strategies for DTx
Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.